Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1801 AL 1815

Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes

El-Ghazawi K, Eyo UB, Peirce SM.

Microcirculation. 2024 Oct;31(7):e12877. doi: 10.1111/micc.12877. Epub 2024 Sep 2.

Glymphotherapeutics for Alzheimer's disease: Time to move the needle

MohanaSundaram A, Mofatteh M, Ashraf GM, Praticò D.

Ageing Res Rev. 2024 Nov;101:102478. doi: 10.1016/j.arr.2024.102478. Epub 2024 Aug 31.

[Calcium Dyshomeostasis and Alzheimer's Disease]

Qi S, Yuan Y, Yang W, Su JY, Hao LY.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Aug;46(4):592-602. doi: 10.3881/j.issn.1000-503X.15789.

Exploring the Frontier: Antisense Long Non-Coding RNAs as Key Regulators in Alzheimer's Disease

Cai J, Ni YQ, Liu YS.

Aging Dis. 2024 Aug 19;16(4):1793-1812. doi: 10.14336/AD.2024.0762.

Emerging Roles of Adaptive Immune Response in Alzheimer's Disease

Li C, Zhao Q, Feng L, Li M.

Aging Dis. 2024 Aug 12;16(4):2315-2342. doi: 10.14336/AD.2024.0564.

Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets

Chauhan A, Dubey S, Jain S.

Cell Biochem Funct. 2024 Sep;42(7):e4111. doi: 10.1002/cbf.4111.

Alzheimer disease-like neuropathologic changes in a geriatric baboon (Papio hamadryas)

Harrison WT, Cline JM, Caudell DL, Huber HF, Shively CA, Register TC, Craft S, Struthers JD.

J Vet Sci. 2024 Sep;25(5):e60. doi: 10.4142/jvs.24080. Epub 2024 Aug 7.

Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer's disease in a European population

Simmonds E, Leonenko G, Yaman U, Bellou E, Myers A, Morgan K, Brookes K, Hardy J, Salih D, Escott-Price V.

Transl Psychiatry. 2024 Sep 4;14(1):358. doi: 10.1038/s41398-024-03058-9.

Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer's Disease: Recent Advances and Therapeutic Implications

Rahman MA, Rahman MDH, Rhim H, Kim B.

Curr Neuropharmacol. 2024;22(12):1942-1959. doi: 10.2174/1570159X22666240426091311.

AMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets

Ning L, Shen R, Xie B, Jiang Y, Geng X, Dong W.

J Neuropathol Exp Neurol. 2024 Nov 1;83(11):895-906. doi: 10.1093/jnen/nlae093.

Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease

Butler T, Tey SR, Galvin JE, Perry G, Bowen RL, Atwood CS.

J Alzheimers Dis. 2024;101(3):705-713. doi: 10.3233/JAD-240334.

Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease

Zhao X, Hu Q, Wang X, Li C, Chen X, Zhao D, Qiu Y, Xu H, Wang J, Ren L, Zhang N, Li S, Gong P, Hou Y.

Eur J Med Chem. 2024 Dec 5;279:116810. doi: 10.1016/j.ejmech.2024.116810. Epub 2024 Sep 4.

The emerging role of exercise in Alzheimer's disease: Focus on mitochondrial function

Feng L, Li B, Yong SS, Wen X, Tian Z.

Ageing Res Rev. 2024 Nov;101:102486. doi: 10.1016/j.arr.2024.102486. Epub 2024 Sep 6.

The Endocannabinoid System in Alzheimer's Disease: A Network Meta-Analysis

Liu Y, Xing H, Zhang Y, Song Y.

J Neurosci Res. 2024 Sep;102(9):e25380. doi: 10.1002/jnr.25380.

Role of the X Chromosome in Alzheimer Disease Genetics

Belloy ME, Le Guen Y, Stewart I, Williams K, Herz J, Sherva R, Zhang R, Merritt V, Panizzon MS, Hauger RL, Gaziano JM, Logue M, Napolioni V, Greicius MD.

JAMA Neurol. 2024 Oct 1;81(10):1032-1042. doi: 10.1001/jamaneurol.2024.2843.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias